There could be a troubling human cost to the race to offer cheaper generic drugs

Shutterstock

• A recent study found that generic drug companies with more competition had a higher number of recalls due to manufacturing problems.
• Higher competition was also found to be associated with lower FDA plant inspection scores.
• The study recommends that the FDA more closely regulate how generic drugs are made and the manufacturing quality of the plants that produce them. 

---

There's a caveat to the availability of cheaper drugs: There's no guarantee on consistent quality. 

These days, generic drugmakers can't seem to win. Consolidation of generic drug companies result in shortages, which negatively impacts patients. But competition has its own consequences as well. 

See the rest of the story at Business Insider

NOW WATCH: What humans will look like on Mars

See Also:

• A $1 billion data-crunching startup that was initially rejected by investors aims to do for drug companies what it did for Netflix
• A hot new type of workout you can do in under 10 minutes is gaining traction, and scientists are into it
• The FDA is sounding the alarm on the next group of drugs that could be abused

SEE ALSO: A bombshell New York Times report says that Purdue Pharma knew OxyContin was being abused within the first few years after it launched

from Business Insider https://ift.tt/2Ht1qwC